SPEAR MATTHEW A. (Chief Medical Officer) sold 8.8% of their position (4K shares) of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $35.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/24/2021ACC: 0001209191-21-053177
Officer· Chief Medical Officer
Since Jul 2020
-4K
Net shares
Net seller
$35.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4K acquired · 8K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4K
Price / share
$1.32
Trade value
$5.29K
% of position
9.6%
8/20/2021
41.48K→45.48K
Common Stock
Direct
Shares
−4K
Price / share
$8.79
Trade value
$35.14K
% of position
8.8%
8/20/2021
45.48K→41.48K
Total
Net shares
+0.00
Net value
-$29.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2021 | M · Option Exercise | +4K | $1.32 | $5.29K | 9.6% | 41.48K | 45.48K |
| Common Stock Direct | 8/20/2021 | S · Sale | −4K | $8.79 | $35.14K | 8.8% | 45.48K | 41.48K |
| Total | +0.00 | -$29.85K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4K shares
Shares
−4K
Strike price
1.322
Held after
90.86K
Exercisable
—
8/20/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4K shares | 8/20/2021 | M · Option Exercise | −4K | 1.322 | — | 90.86K |